ADMP stock news

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 23) Akero Therapeutics Inc (NASDAQ: AKRO ) Mirum Pharmaceuticals Inc (NASDAQ: MIRM )( IPOed June 18) Salarius Pharmaceuticals Inc (NASDAQ: SLRX ) VolitionRX Ltd (NYSE: VNRX ) Down In The Dumps (Biotech stocks hitting 52-week lows on July 23) Abbott Laboratories (NYSE: ABT ) Abeona Therapeutics Inc (NASDAQ: ABEO ) Adamis Pharmaceuticals Corp (NASDAQ: ADMP ) Advaxis, Inc. (NASDAQ: ADXS )(announced pricing of its 9.2 million common stock offering) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) Apollo Endosurgery Inc (NASDAQ: APEN )(slipped ahead of earnings) Applied DNA Sciences Inc (NASDAQ: APDN ) Autolus Therapeutics Ltd – ADR (NASDAQ: AUTL ) Bellicum Pharmaceuticals Inc (NASDAQ: BLCM ) BIOLINERX LTD/S ADR (NASDAQ: BLRX ) Cancer Genetics Inc (NASDAQ: CGIX ) Celldex Therapeutics, Inc. (NASDAQ: CLDX ) China SXT Pharmaceuticals Inc (NASDAQ: SXTC ) Dynavax Technologies Corporation (NASDAQ: DVAX ) Eloxx Pharmaceuticals Inc (NASDAQ: ELOX ) Foamix Pharmaceuticals Ltd (NASDAQ: FOMX ) Gamida Cell Ltd (NASDAQ: GMDA ) GENFIT S A/ADR (NASDAQ: GNFT ) Heat Biologics Inc (NASDAQ: HTBX ) HTG Molecular Diagnostics Inc (NASDAQ: HTGM ) Intra-Cellular Therapies Inc (NASDAQ: ITCI ) Invivo Therapeutics Holdings Corp (NASDAQ: NVIV ) Jaguar Health Inc (NASDAQ: JAGX ) Kaleido Biosciences Inc (NASDAQ: KLDO ) Kindred Biosciences Inc (NASDAQ: KIN ) Marinus Pharmaceuticals Inc (NASDAQ: MRNS )( announced data from a late-stage study of postpartum depression drug) MEI Pharma Inc (NASDAQ: MEIP ) ) Myovant Sciences Ltd (NYSE: MYOV )(announced positive late-stage trial results for drug to treat uterine fibroids and heavy menstrual bleeding) Neon Therapeutics Inc (NASDAQ: NTGN ) Neovasc Inc (NASDAQ: NVCN ) Organogenesis Holdings Inc (NASDAQ: ORGO ) Psychemedics Corp. Read more
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 2) ANI Pharmaceuticals Inc Common Stock (NASDAQ: ANIP ) ArQule, Inc. (NASDAQ: ARQL ) Axsome Therapeutics Inc (NASDAQ: AXSM ) Coherus Biosciences Inc (NASDAQ: CHRS ) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) MeiraGTx Holdings PLC (NASDAQ: MGTX ) ZEALAND PHARMA/S ADR (NASDAQ: ZEAL ) Down In The Dumps (Biotech stocks hitting 52-week lows on July 2) Adamis Pharmaceuticals Corp (NASDAQ: ADMP ) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) Atreca Inc (NASDAQ: BCEL )(IPOed June 20) Biopharmx Corp (NYSE: BPMX ) ContraVir Pharmaceuticals Inc (NASDAQ: CTRV ) Kaleido Biosciences Inc (NASDAQ: KLDO ) Nuvectra Corp (NASDAQ: NVTR ) Personalis Inc (NASDAQ: PSNL ) (IPOed June 20) Prevail Therapeutics Inc (NASDAQ: PRVL ) (IPOed June 20) Sienna Biopharmaceuticals Inc (NASDAQ: SNNA ) Surface Oncology Inc (NASDAQ: SURF ) Tetraphase Pharmaceuticals Inc (NASDAQ: TTPH ) TrovaGene Inc (NASDAQ: TROV ) See Also: Attention Biotech Investors: Mark Your Calendar For These July PDUFA Dates Stocks In Focus Roche's Flu Medication Found Effective And Safe In Children Roche Holdings AG Basel … Read more
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on May 29) Chiasma Inc (NASDAQ: CHMA ) Soliton Inc (NASDAQ: SOLY )( reacted to the news of the initiation of cellulite trial) Eidos Therapeutics Inc (NASDAQ: EIDX ) Down In The Dumps (Biotech stocks hitting 52-week lows on May 29) Abeona Therapeutics Inc (NASDAQ: ABEO ) Adamis Pharmaceuticals Corp (NASDAQ: ADMP ) Adaptimmune Therapeutics PLC – ADR (NASDAQ: ADAP ) Akebia Therapeutics Inc (NASDAQ: AKBA ) Alkermes Plc (NASDAQ: ALKS ) Allena Pharmaceuticals Inc (NASDAQ: ALNA ) Allergan plc (NYSE: AGN ) AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG ) Aptinyx Inc (NASDAQ: APTX ) Arbutus Biopharma Corp (NASDAQ: ABUS ) Axovant Gene Therapies Ltd (NASDAQ: AXGT ) BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX ) CAN-FITE BIOPHA/S ADR (NYSE: CANF )(reacted to its first-quarter results and an update on clinical trial progress) Cidara Therapeutics Inc (NASDAQ: CDTX ) Diplomat Pharmacy Inc (NYSE: DPLO ) Eloxx Pharmaceuticals Inc (NASDAQ: ELOX ) Emergent Biosolutions Inc (NYSE: EBS ) Foamix Pharmaceuticals Ltd (NASDAQ: FOMX ) Hookipa Pharma Inc (NASDAQ: HOOK ) IMMURON LTD/S ADR (NASDAQ: IMRN ) Invivo Therapeutics Holdings Corp (NASDAQ: NVIV ) Melinta Therapeutics Inc (NASDAQ: MLNT ) Opko Health Inc. (NASDAQ: OPK ) Sellas Life Sciences Group Inc (NASDAQ: SLS ) Seres Therapeutics Inc (NASDAQ: MCRB ) Teva Pharmaceutical Industries Ltd (NYSE: TEVA )( downgraded by UBS to Neutral on its legal woes) Theravance Biopharma Inc (NASDAQ: TBPH ) Xenetic Biosciences Inc (NASDAQ: XBIO ) Stock In Focus Unity … Read more
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs on May 21) Array Biopharma Inc (NASDAQ: ARRY ) (announced positive late-stage results for its colorectal cancer combo drug) ZEALAND PHARMA/S ADR (NASDAQ: ZEAL ) Down In The Dumps (Biotech stocks hitting 52-week lows on May 21) Adamis Pharmaceuticals Corp (NASDAQ: ADMP )(announced a patent litigation against it for its naloxone injection product candidate that is currently under regulatory review) BioCryst Pharmaceuticals, Inc (NASDAQ: BCRX )( reacted to late-stage study data for its hereditary angioedema prevention candidate) Cancer Genetics Inc (NASDAQ: CGI ) (reacted to its first-quarter results) Collegium Pharmaceutical Inc (NASDAQ: COLL ) Hookipa Pharma Inc (NASDAQ: HOOK ) (reacted to its first-quarter results) Ocular Therapeutix Inc (NASDAQ: OCUL ) ( reported negative Phase 3 readout for glaucoma treatment candidate) Theravance Biopharma Inc (NASDAQ: TBPH ) (reported Phase 1b data of its gut-selective pan-Janus kinase inhibitor TD-1473 at the Digestive Disease Week 2019) Trillium Therapeutics Inc (NASDAQ: TRIL ) Stock In Focus Tocagen's Brian Cancer Gene Therapy Trials Continue With Modification Tocagen Inc (NASDAQ: TOCA ) announced the Phase 3 trial evaluating its Toca 511 and Toca FC gene therapies in patients with recurrent high grade glioma continues without modification. Read more
Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) announced today conditional acceptance by the U.S. Food and Drug Administration (FDA) of the proposed brand name for the company’s high dose naloxone product candidate. The notification to the company from the FDA noted that after review, the proposed Read more
Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) Q1 2019 Results Earnings Conference Call May 9, 2019 5:00 PM ET Company Participants Dennis Carlo – President a Read more
Adamis (ADMP) delivered earnings and revenue surprises of -11.76% and -17.48%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock? Read more
Adamis Pharmaceuticl (ADMP) shares are under scrutiny today as the Balance of Power has trended lower over multiple sessions. The Balance of Power is a simple indicator and it is used in technical ana Read more
Among 3 analysts covering Adamis Pharmaceuticals (NASDAQ:ADMP), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. Adamis Pharmaceuticals had 5 analyst reports since November 12, 2018 a Read more
The primary goal for some beginner traders might be just trying to survive. Traders that are disciplined with their money management may be able to better ride out the bumps that come with inexperienc Read more
Brokerages expect that Adamis Pharmaceuticals Corp (NASDAQ:ADMP) will report ($0.15) earnings per share (EPS) for the current fiscal quarter, according to Zacks Investment Research. Two analysts have Read more
As Drug Delivery company, Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) is competing with its rivals based on the risk, analyst recommendations, profitability, dividends, earnings and valuation, in Read more

Proudly made at

ROCKIT